77 related articles for article (PubMed ID: 12776196)
1. A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.
Atlas E; Bojanowski K; Mehmi I; Lupu R
Oncogene; 2003 May; 22(22):3441-51. PubMed ID: 12776196
[TBL] [Abstract][Full Text] [Related]
2. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
Menendez JA; Mehmi I; Lupu R
Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
[TBL] [Abstract][Full Text] [Related]
3. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R
Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556
[TBL] [Abstract][Full Text] [Related]
4. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.
Tsai MS; Shamon-Taylor LA; Mehmi I; Tang CK; Lupu R
Oncogene; 2003 Feb; 22(5):761-8. PubMed ID: 12569369
[TBL] [Abstract][Full Text] [Related]
5. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
[TBL] [Abstract][Full Text] [Related]
6. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
[TBL] [Abstract][Full Text] [Related]
7. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
Sun Y; Lin H; Zhu Y; Ma C; Ye J; Luo J
J Cell Physiol; 2002 Aug; 192(2):225-33. PubMed ID: 12115729
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.
Vadlamudi R; Adam L; Tseng B; Costa L; Kumar R
Cancer Res; 1999 Jun; 59(12):2843-6. PubMed ID: 10383144
[TBL] [Abstract][Full Text] [Related]
9. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.
Liu WM; Guerra-Vladusic FK; Kurakata S; Lupu R; Kohwi-Shigematsu T
Cancer Res; 1999 Nov; 59(22):5695-703. PubMed ID: 10582687
[TBL] [Abstract][Full Text] [Related]
10. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
St-Laurent V; Sanchez M; Charbonneau C; Tremblay A
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
[TBL] [Abstract][Full Text] [Related]
11. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
Barnes CJ; Li F; Mandal M; Yang Z; Sahin AA; Kumar R
Cancer Res; 2002 Mar; 62(5):1251-5. PubMed ID: 11888885
[TBL] [Abstract][Full Text] [Related]
12. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
13. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.
Xia W; Liu LH; Ho P; Spector NL
Oncogene; 2004 Jan; 23(3):646-53. PubMed ID: 14737100
[TBL] [Abstract][Full Text] [Related]
14. Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.
Shimizu H; Seiki T; Asada M; Yoshimatsu K; Koyama N
Oncogene; 2003 Feb; 22(6):831-9. PubMed ID: 12584562
[TBL] [Abstract][Full Text] [Related]
15. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
Hijazi MM; Thompson EW; Tang C; Coopman P; Torri JA; Yang D; Mueller SC; Lupu R
Int J Oncol; 2000 Oct; 17(4):629-41. PubMed ID: 10995872
[TBL] [Abstract][Full Text] [Related]
16. Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells.
Tang CK; Perez C; Grunt T; Waibel C; Cho C; Lupu R
Cancer Res; 1996 Jul; 56(14):3350-8. PubMed ID: 8764133
[TBL] [Abstract][Full Text] [Related]
17. Heregulin-alpha and heregulin-beta expression is linked to a COX-2-PGE2 pathway in human gastric fibroblasts.
Nagata K; Wada K; Tatsuguchi A; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1243-51. PubMed ID: 16357062
[TBL] [Abstract][Full Text] [Related]
18. Growth factor regulation of a 26S proteasomal subunit in breast cancer.
Barnes CJ; Li F; Talukder AH; Kumar R
Clin Cancer Res; 2005 Apr; 11(8):2868-74. PubMed ID: 15837734
[TBL] [Abstract][Full Text] [Related]
19. Heregulins implicated in cellular functions other than receptor activation.
Breuleux M; Schoumacher F; Rehn D; Küng W; Mueller H; Eppenberger U
Mol Cancer Res; 2006 Jan; 4(1):27-37. PubMed ID: 16446404
[TBL] [Abstract][Full Text] [Related]
20. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
